The World Health Organization (WHO) is initiating a public comment process for partners and stakeholders to provide inputs on the updated high-priority target product profiles for next-generation drug-susceptibility testing at peripheral centers.
The deadline for submitting comments is 31 January 2021.
For further details about the call, click here.